FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367322415> ?p ?o ?g. }

• W4367322415 endingPage "e47524" @default.
• W4367322415 startingPage "e47524" @default.
• W4367322415 abstract "Innovative approaches are needed to address the self-management needs of youths with osteogenesis imperfecta (OI) transitioning into adult-oriented health care systems. Using a sequentially phased research approach, the goal is to design, develop, and test the usability of an innovative eHealth program called Teens Taking Charge: Managing OI Online, hereafter named Teens OI. This program seeks to optimize self-management, facilitate a successful transition to adult care, and address a critical gap in the quality of care for youths with OI.The study objectives are to (1) design and develop an English and French version of the Teens OI and (2) test the usability of the Teens OI in terms of efficiency, effectiveness, and satisfaction from the perspectives of youths with OI and their parents.A user-centered design is presently in progress to design and develop Teens OI. A Website Design and Development Council (ie, Council) has been convened, with 20 youths and parent dyads recruited and global experts surveyed at an international meeting. With unanimous support from the Council, usability testing of the Teens OI will ensue in 4 iterative cycles with 32 youth-parent dyads. All sociodemographic and usability metrics will be descriptively analyzed. All recorded interview and focus group data are analyzed using content analysis techniques involving an iterative process of data reduction, data display, conclusion drawing, and verification.As of December 2022, an 8-person, interdisciplinary Teens OI council, comprising 4 health care professionals, 3 youths and young adults with OI, and 1 parent, has been convened to oversee the design and development of Teens OI. Two cycles of interviews have been conducted with 10 youths with OI with or without their parents (n=6) from December 2021 to September 2022. Data analysis has been in progress since April 2022. Aim 2 is ethically approved and will commence following the completion of content development, expected by late July 2023. Preliminary analysis indicates that the following topics need to be prioritized for the youths: mental health, pain, accessibility, medical care, education, community, and parental care.The proposed study will design and develop a self-management and transitional care program for youths with OI in partnership with patients, caregivers, and health care professionals. This study leverages youths' openness to adopt eHealth technologies to meet their needs and has the potential to actively engage them to autonomously manage their lifelong conditions, and facilitate a successful transition to adult health care. Finally, the proposed study will also address a critical gap in the quality of care and the growing concern that the OI population transitioning from pediatric to adult care is at risk of various adverse events associated with the transition.DERR1-10.2196/47524." @default.
• W4367322415 created "2023-04-29" @default.
• W4367322415 creator A5013272432 @default.
• W4367322415 creator A5022351783 @default.
• W4367322415 creator A5027269163 @default.
• W4367322415 creator A5031415296 @default.
• W4367322415 creator A5036515194 @default.
• W4367322415 creator A5054352873 @default.
• W4367322415 creator A5059521359 @default.
• W4367322415 creator A5071191094 @default.
• W4367322415 creator A5074414209 @default.
• W4367322415 creator A5080170598 @default.
• W4367322415 creator A5084765622 @default.
• W4367322415 creator A5086161000 @default.
• W4367322415 creator A5091418914 @default.
• W4367322415 date "2023-06-23" @default.
• W4367322415 modified "2023-10-18" @default.
• W4367322415 title "The Design, Development, and Usability Testing of an eHealth Program for Youths With Osteogenesis Imperfecta: Protocol for a 2-Phase User-Centered Mixed Methods Study" @default.
• W4367322415 cites W1596953637 @default.
• W4367322415 cites W1843660700 @default.
• W4367322415 cites W1913410488 @default.
• W4367322415 cites W1962894711 @default.
• W4367322415 cites W1968911030 @default.
• W4367322415 cites W1996600674 @default.
• W4367322415 cites W2010233908 @default.
• W4367322415 cites W2021287292 @default.
• W4367322415 cites W2024095842 @default.
• W4367322415 cites W2029391291 @default.
• W4367322415 cites W2032454112 @default.
• W4367322415 cites W2045923296 @default.
• W4367322415 cites W2063722988 @default.
• W4367322415 cites W2065186812 @default.
• W4367322415 cites W2073045553 @default.
• W4367322415 cites W2089833902 @default.
• W4367322415 cites W2098488564 @default.
• W4367322415 cites W2099473180 @default.
• W4367322415 cites W2117034008 @default.
• W4367322415 cites W2118561145 @default.
• W4367322415 cites W2121431887 @default.
• W4367322415 cites W2136662419 @default.
• W4367322415 cites W2143338422 @default.
• W4367322415 cites W2150697972 @default.
• W4367322415 cites W2153389222 @default.
• W4367322415 cites W2158299212 @default.
• W4367322415 cites W2158446205 @default.
• W4367322415 cites W2158586772 @default.
• W4367322415 cites W2179406570 @default.
• W4367322415 cites W2210627122 @default.
• W4367322415 cites W2277409345 @default.
• W4367322415 cites W2409716549 @default.
• W4367322415 cites W2484982844 @default.
• W4367322415 cites W2731877351 @default.
• W4367322415 cites W2771212050 @default.
• W4367322415 cites W2789393291 @default.
• W4367322415 cites W2798035408 @default.
• W4367322415 cites W2806376860 @default.
• W4367322415 cites W2890050178 @default.
• W4367322415 cites W2894785530 @default.
• W4367322415 cites W2902608782 @default.
• W4367322415 cites W2903440426 @default.
• W4367322415 cites W2916478367 @default.
• W4367322415 cites W2963925147 @default.
• W4367322415 cites W2965749922 @default.
• W4367322415 cites W2981949648 @default.
• W4367322415 cites W2991335692 @default.
• W4367322415 cites W2996625318 @default.
• W4367322415 cites W3007840104 @default.
• W4367322415 cites W3014168532 @default.
• W4367322415 cites W3016137970 @default.
• W4367322415 cites W3021121857 @default.
• W4367322415 cites W4232308982 @default.
• W4367322415 cites W4233904714 @default.
• W4367322415 cites W4284965316 @default.
• W4367322415 cites W54246568 @default.
• W4367322415 cites W79600604 @default.
• W4367322415 doi "https://doi.org/10.2196/47524" @default.
• W4367322415 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37351933" @default.
• W4367322415 hasPublicationYear "2023" @default.
• W4367322415 type Work @default.
• W4367322415 citedByCount "0" @default.
• W4367322415 crossrefType "journal-article" @default.
• W4367322415 hasAuthorship W4367322415A5013272432 @default.
• W4367322415 hasAuthorship W4367322415A5022351783 @default.
• W4367322415 hasAuthorship W4367322415A5027269163 @default.
• W4367322415 hasAuthorship W4367322415A5031415296 @default.
• W4367322415 hasAuthorship W4367322415A5036515194 @default.
• W4367322415 hasAuthorship W4367322415A5054352873 @default.
• W4367322415 hasAuthorship W4367322415A5059521359 @default.
• W4367322415 hasAuthorship W4367322415A5071191094 @default.
• W4367322415 hasAuthorship W4367322415A5074414209 @default.
• W4367322415 hasAuthorship W4367322415A5080170598 @default.
• W4367322415 hasAuthorship W4367322415A5084765622 @default.
• W4367322415 hasAuthorship W4367322415A5086161000 @default.
• W4367322415 hasAuthorship W4367322415A5091418914 @default.
• W4367322415 hasBestOaLocation W43673224151 @default.
• W4367322415 hasConcept C107457646 @default.
• W4367322415 hasConcept C142724271 @default.
• W4367322415 hasConcept C144133560 @default.

• next